News Archives - Page 27 of 1183 - BioHealth Innovation

News

September 9, 2024

$50 Million ‘Build to Scale’ Funding Opportunity Aims to Boost Technology Entrepreneur Ecosystems

The U.S. Economic Development Administration (EDA) is accepting applications for its FY24 $50 million Build to Scale program to support organizations that…

Andy

Love0

News

September 9, 2024

Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis

GAITHERSBURG, Md., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering…

Andy

Love0

News

September 6, 2024

Forbes: Where Are Federal Economic Development Investments Going?

Billions in funding from the CHIPS & Science Act, Bipartisan Infrastructure Law, Inflation Reduction Act, and American Rescue Plan–known as…

Andy

Love0

News

September 5, 2024

BioHealth Capital Region Announces Finalists for the 9th Annual Crab Trap Competition

The BioHealth Capital Region is proud to announce the finalists for this year’s Crab Trap Competition, selected from a highly…

Andy

Love0

News

September 5, 2024

ARPA-H Launches PRECISE-AI to Ensure Long-Term Reliability of AI in Healthcare

ARPA-H has announced a new funding opportunity through its PRECISE-AI program, aimed at maintaining the accuracy and reliability of AI-enabled…

Andy

Love0

News

September 4, 2024

REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect

ROCKVILLE, Md., Sept. 3, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced positive results from the Phase I/II/III CAMPSIITE® trial of RGX-121 for the…

Andy

Love0

News

September 4, 2024

Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network

Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on…

Andy

Love0

News

September 3, 2024

BISNOW: Join the Leaders in Life Sciences and Real Estate at the International Life Sciences Real Estate Conference Next Week in Rockville

The International Life Sciences Real Estate Conference, taking place on September 11-12, 2024, at the Bethesda North Marriott Hotel &…

Andy

Love0

News

September 3, 2024

Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15

GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering…

Andy

Love0

News

September 3, 2024

BioHealth Capital Region Week is Just Two Weeks Away: Register Now!

As we approach the exciting BioHealth Capital Region Week, slated to kick off in just two weeks, there's still time…

Andy

Love0

News

$50 Million ‘Build to Scale’ Funding Opportunity Aims to Boost Technology Entrepreneur Ecosystems

Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis

Forbes: Where Are Federal Economic Development Investments Going?

BioHealth Capital Region Announces Finalists for the 9th Annual Crab Trap Competition

ARPA-H Launches PRECISE-AI to Ensure Long-Term Reliability of AI in Healthcare

REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect

Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network

BISNOW: Join the Leaders in Life Sciences and Real Estate at the International Life Sciences Real Estate Conference Next Week in Rockville

Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15

BioHealth Capital Region Week is Just Two Weeks Away: Register Now!

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search